Financial News
Latest News about NVO
Recent news which mentions NVO
   What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?
   
  
  
  February 05, 2025
  From Benzinga
 
   Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026
   
  
  
  February 05, 2025
  From Benzinga
 
   Earnings Scheduled For February 5, 2025
   
  
  
  February 05, 2025
  From Benzinga
 
   $100 Invested In Novo Nordisk 5 Years Ago Would Be Worth This Much Today
   
  
  
  February 04, 2025
  From Benzinga
 
   Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss
   
  
  
  February 04, 2025
  From Benzinga
 
   Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
   
  February 03, 2025
  Tickers 
   NVO
  
  
  From Benzinga
 
   3 Magnificent Stocks to Buy and Hold Forever
   
  
  
  February 03, 2025
  From Motley Fool
 
   Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
   
  February 02, 2025
  Tickers 
   NVO
  
  
  From Motley Fool
 
   Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
   
  
  
  February 01, 2025
  From Motley Fool
 From Motley Fool
 
   RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
   
  
  
  January 29, 2025
  From Benzinga
 
   5 Monster Stocks to Hold for the Next 10 Years
   
  
  
  January 29, 2025
  From Motley Fool
 
   Ozempic Receives FDA Approval To Treat Kidney Disease
   
  
  
  January 28, 2025
  From Benzinga
 
   How Ozempic And Legal Weed Are Changing What America Eats
   
  
  
  January 28, 2025
  From Benzinga
 From Benzinga
 
   Why Eli Lilly Stock Topped the Market Today
   
  
  
  January 24, 2025
  From Motley Fool
 
   Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?
   
  
  
  January 24, 2025
  From Benzinga
 
   Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
   
  
  
  January 24, 2025
  From Motley Fool
 From Benzinga
 
   Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
   
  
  
  January 24, 2025
  From Benzinga
 From Motley Fool
 From Benzinga
 From Benzinga
 
   Decoding Novo Nordisk's Options Activity: What's the Big Picture?
   
  January 21, 2025
  Tickers 
   NVO
  
  
  From Benzinga
 
   Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
   
  January 21, 2025
  Tickers 
   NVO
  
  
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










